Alnylam Pharmaceuticals
ALNY
#1097
Rank
HK$164.44 B
Marketcap
HK$1,228
Share price
-2.02%
Change (1 day)
-65.71%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company